Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 21,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 21,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 13,842 | 13,271 | 9,418 | 15,726 | 17,542 |
| Operating Income | 7,158 | -13,271 | -9,418 | -15,726 | -17,542 |
| Interest Expense | 475 | 1,368 | 1,369 | 1,341 | 1,301 |
| Other Income | -3,013 | 1,107 | 2,406 | 697 | 861 |
| Pre-tax Income | 3,670 | -13,532 | -8,381 | -16,370 | -17,982 |
| Net Income Continuous | 3,670 | -13,532 | -8,381 | -16,370 | -17,982 |
| Net Income | $3,670 | $-13,532 | $-8,381 | $-16,370 | $-17,982 |
| EPS Basic Total Ops | 0.08 | -0.28 | -0.16 | -0.36 | -0.40 |
| EPS Basic Continuous Ops | 0.08 | -0.28 | -0.16 | -0.36 | -0.40 |
| EPS Diluted Total Ops | 0.08 | -0.28 | -0.17 | -0.36 | -0.40 |
| EPS Diluted Continuous Ops | 0.08 | -0.27 | -0.14 | -0.36 | -0.40 |
| EPS Diluted Before Non-Recurring Items | 0.08 | -0.28 | -0.20 | -0.36 | -0.40 |
| EBITDA(a) | $9,610 | $-12,873 | $-9,018 | $-15,324 | $-17,136 |